Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises iBinder Group in connection with the acquisition of Avima AB
Mandate

Vinge advises iBinder Group in connection with the acquisition of Avima AB

October 07, 2024 M&A Intellectual Property Corporate Commercial Employment and Benefits Corporate Tax IT, Telecommunications and Outsourcing

Avima AB is a Swedish specialist in project and information management, with expertise in complex projects within construction, real estate and infrastructure.

iBinder Group offers digital information management services for the construction and real estate industry. iBinder Group was founded in 2005 and the company helps clients increase productivity, reduce environmental impact and comply with laws and regulations in construction projects and real estate management.

Vinge’s team consisted of Johanna Wiberg, Johanna Hamrefält (Project Manager), Johan Gavelin (IP), Elis Allmark (Commercial/IT), Emelie Svanberg and Victor Ericsson (Tax), Jonna Skog (Employment) and Amelia Rihs (M&A).

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

 Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026